Found 9 matching trials
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG) PHASE1 This is a single-center, open-label, dose-escalation phase I clinical study...
Show More Learn More & Join Trial
ctDNA-guided Treatment Decision-making PHASE2 This is an exploratory, ctDNA-guided, multi-stage clinical study designed t...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI PHASE2 This study is a prospective, open-label, phase II clinical trial, aiming to...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer N/A This is a retrospective, observational, multi-center clinical study of circ...
Show More Location
Multiple Locations
Learn More & Join Trial
Breast Cancer Implementation Science Study With Educational Intervention NA A study uniquely focused on system-based practice change, measuring the imp...
Show More Location
NYU Langone Health
Learn More & Join Trial
Neoadjuvant Dalpiciclib + AI โ SHR-A1811 for HR+/HER2-Low Breast Cancer PHASE2 This is a phase II, single-arm, prospective exploratory study to evaluate t...
Show More Location
Multiple Locations
Learn More & Join Trial
Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids N/A A case-control study was conducted to evaluate the efficacy and mechanism o...
Show More Location
The First Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors PHASE1 This is a non-randomized, open-label, single-arm, multicenter Phase I clini...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies PHASE1 This is a first in human phase 1 study of AG01 an anti-Progranulin/Glycopro...
Show More Location
University of Maryland Greenebaum Comprehensive Cancer Center
Learn More & Join Trial